Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress.

  • González-Amor, María
  • García-Redondo, Ana B
  • Jorge, Inmaculada
  • Zalba, Guillermo
  • Becares, Martina
  • Ruiz-Rodríguez, María J
  • Rodríguez, Cristina
  • Bermeo, Hugo
  • Rodrigues-Díez, Raquel
  • Rios, Francisco J
  • Montezano, Augusto C
  • Martínez-González, Jose
  • Vázquez, Jesús
  • Redondo, Juan Miguel
  • Touyz, Rhian M
  • Guerra, Susana
  • Salaices, Mercedes
  • Briones, Ana M
Interferon-stimulated gene 15 (ISG15) encodes a ubiquitin-like protein that induces a reversible post-translational modification (ISGylation) and can also be secreted as a free form. ISG15 plays an essential role as host-defence response to microbial infection; however, its contribution to vascular damage associated with hypertension is unknown. Bioinformatics identified ISG15 as a mediator of hypertension-associated vascular damage. ISG15 expression positively correlated with systolic and diastolic blood pressure and carotid intima-media thickness in human peripheral blood mononuclear cells. Consistently, Isg15 expression was enhanced in aorta from hypertension models and in angiotensin II (AngII)-treated vascular cells and macrophages. Proteomics revealed differential expression of proteins implicated in cardiovascular function, extracellular matrix and remodelling, and vascular redox state in aorta from AngII-infused ISG15-/- mice. Moreover, ISG15-/- mice were protected against AngII-induced hypertension, vascular stiffness, elastin remodelling, endothelial dysfunction, and expression of inflammatory and oxidative stress markers. Conversely, mice with excessive ISGylation (USP18C61A) show enhanced AngII-induced hypertension, vascular fibrosis, inflammation and reactive oxygen species (ROS) generation along with elastin breaks, aortic dilation, and rupture. Accordingly, human and murine abdominal aortic aneurysms showed augmented ISG15 expression. Mechanistically, ISG15 induces vascular ROS production, while antioxidant treatment prevented ISG15-induced endothelial dysfunction and vascular remodelling. ISG15 is a novel mediator of vascular damage in hypertension through oxidative stress and inflammation.
Repisalud
Publication Artículo científico (JournalArticle)

Women's health: an imAging-based cardiovascular risK-rEdUction Program (WAKE UP) study. Rationale and design.

  • Wasniewski, Samantha
  • Kfouri Da Silva, Rafaella
  • Capdeville, Sofía
  • Rivera Molina, Isabel
  • Virosta, Elena
  • Ortiz Cortés, Carolina
  • Díez-Villanueva, Pablo
  • Adeba, Antonio
  • Ruiz Lera, Marta
  • Muñoz, Lucía
  • Alonso, David
  • García, Eva
  • Echeverría, Ruth
  • Tarifa, Rocío
  • Ferrarini, Alessia
  • Pagán, Josué
  • Ayala, Jose Luis
  • Solis, Jorge
  • Wood, Malissa
  • Miranda, Blanca
  • Rodríguez Padial, Luis
  • Fernández-Friera, Leticia
Cardiovascular (CV) disease is the leading cause of death in women. Although 80% of CV disease events can be prevented, mortality is projected to increase, particularly in young women. Objectives: To promote CV health in women and encourage appropriate lifestyle changes by increasing awareness through vascular ultrasound imaging. WAKE UP is a prospective case-control study in a target population of 720 asymptomatic women, aged 40-70 years with >= 1 major CV risk factor (RF). Participants will attend a baseline visit and follow-up visits at 6 and 12-months. Each visit will include the assessment of traditional and non-traditional risk factors (age, blood pressure, weight, smoking, diet, physical activity, psychosocial aspects, reproductive factors, family lifestyle), CV risk scores [Fuster-BEWAT Score (FBS) and SCORE], perception of CV disease risk, blood sampling of hormones, lipids, glycemic metabolism, inflammation parameters and omics. At baseline visit, women will be randomized to undergo 2D/3D/strain vascular ultrasound (360 with imaging vs. 360 age- and RF-matched controls without imaging). Main outcomes will include changes from baseline to follow-up in overall knowledge, attitudes, and FBS. WAKE UP trial aims to raise awareness about womens CV disease and promote lifestyle changes. Imaging can play a key role by revealing the presence of atherosclerotic plaques in a directly relatable way and thus, larger effects are anticipated in women with plaques. WAKE UP can significantly impact CV prevention by involving innovative actions addressing a major public health need and by fostering complementary and synergistic actions.
Repisalud
Publication Artículo científico (JournalArticle)

The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development

  • Gomez-del Arco, Pablo
  • Isern, Joan
  • Jimenez-Carretero, Daniel
  • Lopez-Maderuelo, Dolores
  • Piñeiro-Sabarís, Rebeca
  • El Abdellaoui-Soussi, Fadoua
  • Torroja, Carlos
  • Vera-Pedrosa, María Linarejos
  • Grima-Terrén, Mercedes
  • Benguria, Alberto
  • Simón-Chica, Ana
  • Queiro-Palou, Antonio
  • Dopazo, Ana
  • Sanchez-Cabo, Fatima
  • Jalife, Jose
  • de la Pompa, Jose Luis
  • Filgueiras-Rama, David
  • Munoz-Canoves, Pura
  • Redondo, Juan Miguel
Extensive genetic studies have elucidated cardiomyocyte differentiation and associated gene networks using single-cell RNA-seq, yet the intricate transcriptional mechanisms governing cardiac conduction system (CCS) development and working cardiomyocyte differentiation remain largely unexplored. Here we show that mice deleted for Dhx36 (encoding the Dhx36 helicase) in the embryonic or neonatal heart develop overt dilated cardiomyopathy, surface ECG alterations related to cardiac impulse propagation, and (in the embryonic heart) a lack of a ventricular conduction system (VCS). Heart snRNA-seq and snATAC-seq reveal the role of Dhx36 in CCS development and in the differentiation of working cardiomyocytes. Dhx36 deficiency directly influences cardiomyocyte gene networks by disrupting the resolution of promoter G-quadruplexes in key cardiac genes, impacting cardiomyocyte differentiation and CCS morphogenesis, and ultimately leading to dilated cardiomyopathy and atrioventricular block. These findings further identify crucial genes and pathways that regulate the development and function of the VCS/Purkinje fiber (PF) network.
Repisalud
Publication Artículo científico (JournalArticle)

Interplay between the Chd4/NuRD Complex and the Transcription Factor Znf219 Controls Cardiac Cell Identity

  • El Abdellaoui-Soussi, Fadoua
  • Yunes-Leites, Paula Sofia
  • Lopez-Maderuelo, Dolores
  • Garcia-Marques, Fernando
  • Vazquez, Jesus
  • Redondo, Juan Miguel
  • Gómez-Del Arco, Pablo
The sarcomere regulates striated muscle contraction. This structure is composed of several myofibril proteins, isoforms of which are encoded by genes specific to either the heart or skeletal muscle. The chromatin remodeler complex Chd4/NuRD regulates the transcriptional expression of these specific sarcomeric programs by repressing genes of the skeletal muscle sarcomere in the heart. Aberrant expression of skeletal muscle genes induced by the loss of Chd4 in the heart leads to sudden death due to defects in cardiomyocyte contraction that progress to arrhythmia and fibrosis. Identifying the transcription factors (TFs) that recruit Chd4/NuRD to repress skeletal muscle genes in the myocardium will provide important information for understanding numerous cardiac pathologies and, ultimately, pinpointing new therapeutic targets for arrhythmias and cardiomyopathies. Here, we sought to find Chd4 interactors and their function in cardiac homeostasis. We therefore describe a physical interaction between Chd4 and the TF Znf219 in cardiac tissue. Znf219 represses the skeletal-muscle sarcomeric program in cardiomyocytes in vitro and in vivo, similarly to Chd4. Aberrant expression of skeletal-muscle sarcomere proteins in mouse hearts with knocked down Znf219 translates into arrhythmias, accompanied by an increase in PR interval. These data strongly suggest that the physical and genetic interaction of Znf219 and Chd4 in the mammalian heart regulates cardiomyocyte identity and myocardial contraction.
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Women's health: an imAging-based cardiovascular risK-rEdUction Program (WAKE UP) study. Rationale and design

  • Wasniewski, Samantha
  • Kfouri Da Silva, Rafaella|||0009-0006-1675-2436
  • Capdeville, Sofia|||0000-0002-9913-2921
  • Rivera Molina, Isabel|||0009-0007-2593-8387
  • Virosta, Elena
  • Ortiz Cortes, Carolina
  • Diez Villanueva, Pablo
  • Adeba García, Antonio|||0000-0003-1786-9565
  • Ruiz Lera, Marta
  • Muñoz Prejigueiro, Lucia|||0009-0004-8925-0379
  • Alonso Rodríguez, David
  • García, Eva
  • Echeverría Orellana, Ruth|||0000-0001-5886-6753
  • Tarifa Conejero, Rocío
  • Ferrarini, Alessia|||0000-0002-4587-6095
  • Pagán Ortiz, Josué|||0000-0002-8357-7950
  • Ayala Rodrigo, José Luis|||0000-0001-7236-5330
  • Solís Martín, Jorge
  • Wood, Malissa
  • Miranda, Blanca
  • Rodríguez Padial, Luis|||0000-0002-5783-3922
  • Fernández Friera, Leticia|||0000-0002-4237-2166